Evidence map›Paper›PMID 35164563›Full record

ArticlemBio2021

Interaction Tolerance Detection Test for Understanding the Killing Efficacy of Directional Antibiotic Combinations.

Jia-Feng Liu, Orit Gefen, Zi-Yin Zhang, Min-Min Liu, Maskit Bar-Meir, Nathalie Q Balaban

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Broad-spectrum tolerance to disinfectant-mediated bacterial killing due to mutation of the PheS aminoacyl tRNA synthetase.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Effects of osmotic stress onItalian journal of food safety · 2023
    Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Jia-Feng LiuRacah Institute of Physics, Edmond J. Safra Campus, The Hebrew University of Jerusalemgrid.9619.7, Jerusalem, Israel.
Orit GefenRacah Institute of Physics, Edmond J. Safra Campus, The Hebrew University of Jerusalemgrid.9619.7, Jerusalem, Israel.
Zi-Yin ZhangCenter for Infectious Disease Research, School of Medicine, Tsinghua Universitygrid.12527.33, Beijing, China.
Min-Min LiuCenter for Infectious Disease Research, School of Medicine, Tsinghua Universitygrid.12527.33, Beijing, China.
Maskit Bar-MeirPaediatrics and Infectious Diseases Division, Shaare Zedek Medical Centergrid.415593.f, Jerusalem, Israel.ORCID 0000-0003-1616-2111
Nathalie Q BalabanRacah Institute of Physics, Edmond J. Safra Campus, The Hebrew University of Jerusalemgrid.9619.7, Jerusalem, Israel.
Hebrew University of Jerusalem · ILTsinghua University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Combination treatments are commonly prescribed for enhancing drug efficacy, as well as for preventing the evolution of resistance. The interaction between drugs is typically evaluated near the MIC, using growth rate as a measure of treatment efficacy. However, for infections in which the killing activity of the treatment is important, measurements far above the MIC are needed. In this regime, the killing rate often becomes weakly concentration dependent, and a different metric is needed to characterize drug interactions. We evaluate the interaction metric on killing using an easy visual assay, the interaction tolerance detection test (iTDtest), that estimates the survival of bacteria under antibiotic combinations. We identify antibiotic combinations that enable the eradication of tolerant bacteria. Furthermore, the visualization of the antibiotic interactions reveals directional drug interactions and enables predicting high-order combination outcomes, therefore facilitating the determination of optimal treatments.

Indexed as

Anti-Bacterial AgentsMicrobial Sensitivity TestsAnti-Bacterial Agentsantibiotic persistenceantimicrobial activityantimicrobial agentsantimicrobial combinationssynergytolerance

Identifiers

PMID35164563
PMCPMC8844919
OpenAlexW4212960604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.